Phase 1 of the CFP Weight Loss Protocol, known as Fat Loading, serves as the critical foundation for a successful metabolic reset. Rather than jumping straight into aggressive calorie restriction, this preparatory stage strategically loads the body with high-quality fats while initiating anti-inflammatory and hormone-sensitizing processes. Under Russell Clark’s clinical guidance, this phase primes the system for efficient fat oxidation, restores leptin sensitivity, and quiets systemic inflammation measured by CRP.
The conventional CICO model fails because it ignores hormonal signaling. Clark’s approach instead prioritizes nutrient density, mitochondrial efficiency, and the complex interplay between GIP and GLP-1 pathways. By the end of this 10-14 day loading window, participants typically report stabilized energy, reduced cravings, and measurable improvements in body composition before entering the more intense Phase 2: Aggressive Loss.
Understanding the Metabolic Terrain Before Loading
Before beginning any fat-loading protocol, Clark recommends establishing baseline biomarkers. Key metrics include HOMA-IR to gauge insulin resistance, hs-CRP for inflammation levels, and detailed body composition analysis beyond simple scale weight. These markers reveal how chronic exposure to lectins and refined carbohydrates has impaired mitochondrial efficiency and muted leptin signaling.
Leptin resistance develops when constant high-sugar intake and visceral fat create a fog that prevents the brain from accurately reading satiety signals. The anti-inflammatory protocol in Phase 1 directly targets this by removing lectin-containing foods and emphasizing low-toxin, nutrient-dense options. Bok choy, for instance, becomes a staple vegetable due to its exceptional nutrient density, negligible lectin content, and ability to support natural detoxification pathways.
Mitochondrial health sits at the core of Clark’s philosophy. When mitochondria operate inefficiently, they produce excessive reactive oxygen species, leading to fatigue and metabolic slowdown. Strategic fat loading combined with cofactors like adequate Vitamin C helps stabilize mitochondrial membrane potential, setting the stage for the ketone production that will dominate later phases.
The Strategic Role of Tirzepatide in Phase 1
The 30-Week Tirzepatide Reset utilizes a single 60 mg box cycled thoughtfully across multiple phases. During Fat Loading, patients begin with micro-dosing via subcutaneous injection, typically 2.5 mg once weekly. This gentle introduction allows the dual GIP and GLP-1 receptor agonist to begin recalibrating appetite and lipid metabolism without overwhelming the system.
GIP’s role extends beyond insulin secretion. It modulates how adipocytes store and release fat while influencing central nervous system pathways that govern energy balance. When paired with GLP-1 activity, the medication enhances satiety, slows gastric emptying, and begins improving leptin sensitivity. Clark emphasizes proper injection technique—rotating sites between abdomen, thighs, and upper arms—to prevent localized reactions and ensure consistent absorption.
Importantly, this is not about using the medication as a crutch. The goal remains a true metabolic reset where the body eventually maintains its new setpoint naturally. Phase 1 dosing serves as the opening act in a carefully orchestrated 70-day cycle that includes Phase 2’s aggressive loss and the Maintenance Phase.
Nutritional Framework: What to Eat During Fat Loading
Phase 1 nutrition focuses on high healthy fat intake paired with moderate protein and very low carbohydrates. The emphasis remains on food quality rather than strict calorie counting. Participants consume approximately 60-70% of calories from fats sourced from avocado, olive oil, wild-caught fish, grass-fed meats, and nuts low in inflammatory compounds.
Protein intake is calibrated to preserve lean muscle mass and support basal metabolic rate (BMR). Because muscle tissue burns significantly more calories at rest than fat, protecting it during any weight loss journey prevents the metabolic adaptation that often leads to rebound weight gain. Clark’s patients typically target 1.6-2.0 grams of protein per kilogram of ideal body weight.
Vegetables are chosen for their nutrient density and low lectin profile. Alongside bok choy, approved options include cruciferous vegetables, leafy greens, and select low-toxin roots. These provide fiber, micronutrients, and volume that satisfy the brain’s need for nutrients, breaking the cycle of hidden hunger that drives overeating.
Meal timing aligns with circadian rhythms to optimize hormonal response. Most calories, particularly fats, are consumed earlier in the day when insulin sensitivity remains higher. This approach challenges the outdated CICO paradigm by demonstrating that when, what, and how food is consumed matters more than simple arithmetic.
Clinical Markers and Expected Physiological Changes
During the Fat Loading phase, patients often experience several positive shifts. Energy levels stabilize as the body begins transitioning toward fat utilization. Cravings diminish as leptin sensitivity starts returning and GLP-1 signaling strengthens satiety centers in the brain.
Laboratory improvements typically appear within two weeks. CRP levels begin declining as the anti-inflammatory protocol reduces systemic “fire.” HOMA-IR scores improve, reflecting better insulin dynamics. Body composition scans reveal early favorable shifts—slight increases in lean mass percentage even before major fat loss occurs.
Some individuals report mild symptoms during the transition, including temporary fatigue or headaches as the body adjusts its primary fuel source. Clark recommends supporting mitochondrial function through targeted supplementation, proper hydration, and stress management to smooth this adaptation period.
The production of modest ketone levels during late Phase 1 signals that metabolic flexibility is returning. These ketones not only provide steady brain fuel but also exert anti-inflammatory effects that further support the protocol’s goals.
Transitioning Successfully into Phase 2 Aggressive Loss
The true test of Phase 1’s effectiveness comes in how smoothly the body moves into the 40-day Aggressive Loss window. When Fat Loading is optimized, patients enter Phase 2 with improved leptin sensitivity, lower inflammation, and mitochondria primed for efficient fat burning.
Clark’s clinical experience shows that those who fully embrace the loading principles lose fat more effectively and sustainably during subsequent phases. The Maintenance Phase that follows becomes about solidifying new habits rather than fighting constant rebound hunger.
Success requires viewing Phase 1 not as a waiting period but as active metabolic preparation. Every high-quality fat molecule consumed, every lectin avoided, and every micro-dose of tirzepatide administered works synergistically to retrain cellular signaling.
By addressing root causes—mitochondrial inefficiency, hormonal resistance, and chronic inflammation—the CFP protocol offers more than temporary weight loss. It delivers a comprehensive metabolic reset that empowers long-term health independence.
Patients following Clark’s guidance frequently report not just changed bodies but transformed relationships with food and energy. The 30-week tirzepatide cycle becomes a temporary tool that facilitates lasting change rather than lifelong dependency. Through strategic Phase 1 optimization, the foundation is laid for sustainable fat loss, improved body composition, and renewed metabolic vitality that extends far beyond the scale.